Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Cuker

Showing results (1-10 of 257) with videos related to

Pageof 26
Sort By:
Blood|March 7, 2015
ITP and TTP: interpreting evidence in light of patient valuesAdam Cuker
Clinical Advances in Hematology & Oncology : H&O|July 8, 2021
Thrombosis with thrombocytopenia syndrome after COVID-19 vaccinationAdam Cuker
Blood|November 3, 2012
Are 25 antibodies better than 1?Adam Cuker
Blood|June 18, 2016
Adjuvant rituximab to prevent TTP relapseAdam Cuker
Blood|February 6, 2016
Does my patient have HIT? There should be an app for thatAdam Cuker
Journal of Thrombosis and Thrombolysis|February 18, 2011
Heparin-induced thrombocytopenia: present and futureAdam Cuker
Seminars in Thrombosis and Hemostasis|December 24, 2013
Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approachAdam Cuker
Thrombosis and Haemostasis|April 15, 2016
Management of the multiple phases of heparin-induced thrombocytopeniaAdam Cuker
Annals of Internal Medicine|December 18, 2013
ACP Journal Club. Risk-stratified vs routine antithrombotics for TKA: fewer wound complications without increasing DVTAdam Cuker
Thrombosis and Haemostasis|October 21, 2011
Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosisAdam Cuker
Pageof 26

Showing results (1-10 of 257) with videos related to

Sort By:
Pageof 26
Blood|March 7, 2015
ITP and TTP: interpreting evidence in light of patient valuesAdam Cuker
Clinical Advances in Hematology & Oncology : H&O|July 8, 2021
Thrombosis with thrombocytopenia syndrome after COVID-19 vaccinationAdam Cuker
Blood|November 3, 2012
Are 25 antibodies better than 1?Adam Cuker
Blood|June 18, 2016
Adjuvant rituximab to prevent TTP relapseAdam Cuker
Blood|February 6, 2016
Does my patient have HIT? There should be an app for thatAdam Cuker
Journal of Thrombosis and Thrombolysis|February 18, 2011
Heparin-induced thrombocytopenia: present and futureAdam Cuker
Seminars in Thrombosis and Hemostasis|December 24, 2013
Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approachAdam Cuker
Thrombosis and Haemostasis|April 15, 2016
Management of the multiple phases of heparin-induced thrombocytopeniaAdam Cuker
Annals of Internal Medicine|December 18, 2013
ACP Journal Club. Risk-stratified vs routine antithrombotics for TKA: fewer wound complications without increasing DVTAdam Cuker
Thrombosis and Haemostasis|October 21, 2011
Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosisAdam Cuker
Pageof 26